Table
of Contents
|
|
|
|
|
|
Introduction |
1 |
|
|
Definition of Terms |
1 |
|
|
Incidence |
2 |
|
|
Preparation for Cervical Ripening,
Induction, or Augmentation |
4 |
|
|
Indications |
4 |
|
|
Risk-Benefit
Analysis and Informed Consent |
5 |
|
|
Assessment |
9 |
|
|
Documentation |
12 |
|
|
Clinical Protocol
and Unit Policy Development |
13 |
|
|
Oxytocin as a High-Alert
Medication |
13 |
|
|
Staffing
Considerations |
15 |
|
|
Cervical Ripening |
16 |
|
|
Mechanical Methods |
16 |
|
|
Pharmacologic Methods |
18 |
|
|
Prostaglandin E2 |
18 |
|
|
Prepidil |
18 |
|
|
Cervidil |
22 |
|
|
Prostaglandin
E1/Misoprostol |
23 |
|
|
Induction and Augmentation of Labor |
25 |
|
|
Mechanical Methods
of Induction of Labor |
25 |
|
|
Stripping the
Membranes |
25 |
|
|
Amniotomy |
26 |
|
|
Pharmacologic
Methods of Induction of Labor |
27 |
|
|
Oxytocin |
27 |
|
|
Dosage and Rate
Increase Intervals |
28 |
|
|
Administration |
30 |
|
|
Management of Oxytocin-Induced
Tachysystole |
31 |
|
|
Misoprostol |
34 |
|
|
Augmentation of Labor |
34 |
|
|
Active Management of
Labor |
35 |
|
|
Induction for Women
Attempting Vaginal Birth After Cesarean Birth (VBAC) |
36 |
|
|
Summary |
37 |
|
|
References |
39 |
|
Appendix A |
Cervical Ripening and Induction of
Labor Analysis |
49 |
|
Appendix B |
Sample Policy: Induction/Augmentation
of Labor with Oxytocin |
50 |
|
Appendix C |
Summary of Research Comparing Oxytocin
Dosages and Intervals |
53 |
|
|
|
|